Proteomics International Laboratories Ltd Diabetes Drug, Canagliflozin, Lowers PromarkerD Diabetic Kidney Disease Risk Prediction Scores
Proteomics International Laboratories Ltd in collaboration with Janssen Research & Development have shown that treatment with Canagliflozin lowers the PromarkerD risk score for developing... | May 3, 2023
New South Wales Vik Malik Richard Lipscombe Proteomics International Laboratories Proteomics International Company Announcement
Source: marketscreener.com